Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Asian Journal of Andrology
|
December 2, 2016
Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer
Xiang Xu, Yu-Hua Huang, Yan-Jing Li, et al.
Spine
|
January 19, 2010
Major intraoperative neurologic monitoring deficits in consecutive pediatric and adult spinal deformity patients at one institution
Jonathan R Kamerlink, Thomas Errico, Shaun Xavier, et al.
Molecular Cancer Research : MCR
|
February 3, 2016
The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma
Wei Li, Alexa Cohen, Yin Sun, et al.
American Journal of Perinatology
|
September 17, 2024
Machine Learning for the Prediction of Surgical Morbidity in Placenta Accreta Spectrum
Itamar D Futterman, Olivia Sher, Chaskin Saroff, et al.
British Journal of Haematology
|
November 23, 2017
Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma
Alexa Cohen, Tanya M Spektor, Laura Stampleman, et al.
Experimental Hematology
|
April 13, 2022
A phase 1/2 study of ixazomib in place of bortezomib or carfilzomib in a subsequent line of therapy for patients with multiple myeloma refractory to their last bortezomib or carfilzomib combination regimen
David Daniely, Eli Forouzan, Tanya M Spektor, et al.
American Journal of Obstetrics & Gynecology MFM
|
May 18, 2024
Investigation of health inequities in maternal and neonatal outcomes of patients with placenta accreta spectrum: a multicenter study
Alexa Cohen, Calvin Lambert, Megan Yanik, et al.
Experimental Hematology
|
August 7, 2022
Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen
Jonathan Afari, Tanya M Spektor, Carley Turner, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 4, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study
Mingfei Yan, Sameer A Parikh, Michelly K Sampaio De Melo, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Asian Journal of Andrology
|
December 2, 2016
Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer
Xiang Xu, Yu-Hua Huang, Yan-Jing Li, et al.
Spine
|
January 19, 2010
Major intraoperative neurologic monitoring deficits in consecutive pediatric and adult spinal deformity patients at one institution
Jonathan R Kamerlink, Thomas Errico, Shaun Xavier, et al.
Molecular Cancer Research : MCR
|
February 3, 2016
The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma
Wei Li, Alexa Cohen, Yin Sun, et al.
American Journal of Perinatology
|
September 17, 2024
Machine Learning for the Prediction of Surgical Morbidity in Placenta Accreta Spectrum
Itamar D Futterman, Olivia Sher, Chaskin Saroff, et al.
British Journal of Haematology
|
November 23, 2017
Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma
Alexa Cohen, Tanya M Spektor, Laura Stampleman, et al.
Experimental Hematology
|
April 13, 2022
A phase 1/2 study of ixazomib in place of bortezomib or carfilzomib in a subsequent line of therapy for patients with multiple myeloma refractory to their last bortezomib or carfilzomib combination regimen
David Daniely, Eli Forouzan, Tanya M Spektor, et al.
American Journal of Obstetrics & Gynecology MFM
|
May 18, 2024
Investigation of health inequities in maternal and neonatal outcomes of patients with placenta accreta spectrum: a multicenter study
Alexa Cohen, Calvin Lambert, Megan Yanik, et al.
Experimental Hematology
|
August 7, 2022
Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen
Jonathan Afari, Tanya M Spektor, Carley Turner, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 4, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study
Mingfei Yan, Sameer A Parikh, Michelly K Sampaio De Melo, et al.
Page
of 3